Literature DB >> 10209177

Mortality in patients with epilepsy: 40 years of follow up in a Dutch cohort study.

D P Shackleton1, R G Westendorp, D G Trenité, J P Vandenbroucke.   

Abstract

To investigate the extent of and the causes of excess mortality in patients with epilepsy, mortality was studied in a cohort of patients with newly diagnosed epilepsy over an extended follow up period. All patients (both inpatients and outpatients) of the Instituut voor Epilepsiebestrijding in Heemstede, the Netherlands between 1953 and 1967 were included in the study. Complete follow up was obtained for 1355 patients, 746 men and 609 women. The mean follow up was 28 years (range 6 months-41 years). In total, 38 665 person years were surveyed, in which 404 patients died. All cause mortality was threefold increased (risk ratio (RR) 3.2; 95%CI 2.9-3. 5), and was only slightly higher for men than for women. Mortality was highest under 20 years of age (RR 7.6; 95%CI 6.5-8.7), and during the first 2 years of follow up (RR 16; 95%CI 12-20). Mortality directly related to epilepsy accounted for 18 of the 53 deaths in the first 2 years after diagnosis, which is equivalent to an incidence rate of 6.8 per 1000 person-years (95% CI 4.1-10). After 2 years 110 of the 351 deaths could be attributed to epilepsy itself, or were epilepsy related, with an incidence rate of 3.1 per 1000 person-years (95% CI 2.5-3.6). The data presented suggest that the increased mortality risk in patients with epilepsy is attributable in part to epilepsy itself, and is predominantly present at younger age and early after diagnosis. However, the absolute risk is moderate.

Entities:  

Mesh:

Year:  1999        PMID: 10209177      PMCID: PMC1736329          DOI: 10.1136/jnnp.66.5.636

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

Review 1.  Recent developments in neurology.

Authors:  Samuel Wiebe; Michael W Nicolle
Journal:  BMJ       Date:  2002-03-16

2.  Deaths from epilepsy: what next?

Authors:  W Henry Smithson; N Jane Hanna
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

3.  The general practitioner with a special interest: new opportunities or the end of the generalist practitioner?

Authors:  Clare Gerada; Nat Wright; Jenny Keen
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

4.  Mortality in Epilepsy.

Authors:  Anne Berg
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

5.  Epidemiology in Epilepsy.

Authors:  Ann T. Berg
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

Review 6.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

Review 7.  How to avoid a misdiagnosis in patients presenting with transient loss of consciousness.

Authors:  Sanjiv Petkar; Paul Cooper; Adam P Fitzpatrick
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

8.  Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.

Authors:  H Y Chong; Z Mohamed; L L Tan; D B C Wu; F H Shabaruddin; M Dahlui; Y D Apalasamy; S R Snyder; M S Williams; J Hao; L H Cavallari; N Chaiyakunapruk
Journal:  Br J Dermatol       Date:  2017-09-21       Impact factor: 9.302

9.  Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study.

Authors:  Olli Nevalainen; Jani Raitanen; Hanna Ansakorpi; Miia Artama; Jouko Isojärvi; Anssi Auvinen
Journal:  Eur J Epidemiol       Date:  2013-09-26       Impact factor: 8.082

Review 10.  Identification of pharmacoresistant epilepsy.

Authors:  Anne T Berg
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.